Skip to main content
logo
Guided Therapeutics, Inc. (GTHP)
OTCMKTS · Delayed Price · Currency is USD
0.1500
-0.0400 (-21.05%)
At close: Oct 21, 2026

Guided Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.650.770.010.10.010.08
Revenue Growth
450.85%10857.14%-92.86%653.85%-83.95%-20.59%
Gross Profit
0.490.5700.04-0.070.02
Operating Income
-1.98-2.37-2.11-2.72-3.33-2.36
Net Income
-3.64-3.35-2.59-3.76-4.97-2.43
Earnings Per Share
-0.04-0.04-0.05-0.07-0.15-0.18
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.010.060.390.592.310.64
Total Debt
2.792.942.161.962.262.9
Net Cash (Debt)
-2.77-2.88-1.77-1.370.05-2.26
Net Cash Growth
------
Net Cash Per Share
-0.03-0.04-0.03-0.030.00-0.17

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1.5-1.07-1.12-1.75-1.48-1.59
Capital Expenditures
-0-0---0.03-0.01
Free Cash Flow
-1.51-1.07-1.12-1.75-1.51-1.61
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
75.69%74.45%28.57%36.73%-24.69%
Operating Margin
-303.85%-309.26%-30114.29%-2773.29%-25638.46%-2916.05%
Pretax Margin
-471.54%-416.69%-34528.57%-3560.20%-33392.31%-2555.56%
Profit Margin
-560.62%-436.25%-37014.29%-3835.71%-38246.15%-3001.24%
FCF Margin
-231.69%-139.50%-15985.71%-1781.63%-11615.39%-1982.72%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
28.2260.661395.6684.751121.4497.66